Design and Fabrication of 3d-printed Capsules for Enhanced Bioavailability of Dronedarone Hydrochloride with Omega-3 Fatty Acids
Matijasic, Gordana
Prebeg, Teodora
Fiala, Emanuel-Nino
Logar, Mirta
Pdf

How to Cite

Matijasic G., Prebeg T., Fiala E.-N., Logar M., 2025, Design and Fabrication of 3d-printed Capsules for Enhanced Bioavailability of Dronedarone Hydrochloride with Omega-3 Fatty Acids, Chemical Engineering Transactions, 117, 1189-1194.
Pdf

Abstract

The aim of this study is to develop and 3D print a capsule containing dronedarone hydrochloride as the primary active ingredient in a polymer filament and omega-3 fatty acid powder as an excipient. The research hypothesis is that the bioavailability of dronedarone hydrochloride is increased by the presence of omega-3 fatty acids. A capsule was formulated and evaluated that allows the simultaneous administration of dronedarone hydrochloride and omega-3 fatty acids. Prior to the 3D printing process, a 3D capsule model was developed using CAD software. Filaments were then extruded with two formulations containing 10 % and 15 % dronedarone. The capsules were then filled with omega-3 fatty acid powder and the in vitro release of dronedarone was tested. Capsules with and without omega-3 fatty acids were tested. The release profiles of dronedarone were compared and the differences were quantified using difference and similarity factors.
The results showed that the samples with omega-3 fatty acids had a faster in vitro release of dronedarone than the samples without this excipient. In addition, a faster release was observed in samples with a higher dronedarone content in the filament, which can be attributed to an increased driving force. The difference and similarity factors showed a statistically significant difference in the release profiles of dronedarone from capsules with omega-3 fatty acids compared to capsules without this excipient.
Pdf